Facilitated By

San Antonio Medical Foundation

To define scope and limitations of cyanation reaction using Ar-Imidazole sulfonates substrates with K3Fe(CN)6

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Frantz Douglas
Funded by
Bristol-Myers Squibb
Research Start Date
Status
Inactive

Basic Research

Collaborative Project
Basic Research
Drug Discovery
Other